AusculSciences

What AusculSciences does

AusculSciences Inc. is a privately held, Ontario-incorporated medical technology company with operational headquarters in Vienna, Virginia, developing hardware-plus-software clinical diagnostic and monitoring devices for the cardiovascular and infection-control segments of inpatient care.

The company's product portfolio is organized around two core systems. The first, Auscul-X, is a touch-free, multi-channel disposable electronic stethoscope system: six high-fidelity disposable acoustic sensors worn on the patient's torso via gel-based adhesive pads capture heart, lung, and internal organ sounds; an in-room Auscul-X control unit transmits these via Wi-Fi to a clinician who can listen remotely through the AirScope mobile application (available on Apple, Android, and Windows) for up to 3 meters of distance. The companion Auscul-XV server software supports recording, annotation, and sharing of auscultation records across consults and shift-changes. Disposable single-patient-use sensors are designed to eliminate cross-contamination between patients and to reduce PPE consumption by minimizing room-entry cycles. The second, CAD-det, is a non-invasive cardiovascular assessment support device intended for adult patients undergoing clinical evaluation for suspected coronary artery disease; it is designed to detect turbulent blood flow in stenosed coronary arteries, positioned against the diagnostic limitations of the exercise stress test (67% sensitivity, 46% specificity) and the cost and radiation burden of CCTA and ICA.

Commercially, the company sells to hospitals, emergency departments, ICUs, and cardiology clinics through direct enterprise engagement and through regional channel partners, per its privacy-policy disclosures. No pricing is publicly disclosed, no certifications or regulatory clearances (e.g., FDA, Health Canada) are confirmed in the input data, no funding rounds are disclosed, and there is no disclosed customer base or installed-unit count. The firm operates with 11–50 employees, and its presence at the time of the inputs consists of an active website, two launched product lines, and ongoing platform development — consistent with an early-stage, possibly pre-commercial medical device developer rather than a scaled commercial entity.

Name

AusculSciences

Legal name

AusculSciences Inc.

Website

https://ausculsciences.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

AusculSciences Inc. is a private Canadian-incorporated medical technology company (operational HQ in Vienna, Virginia) that develops the Auscul-X touch-free disposable electronic stethoscope system and the CAD-det non-invasive cardiovascular assessment device for hospitals, ICUs, and cardiology clinics.

Ownership category

akta.pro rank

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Distribution channels2 records

Marketing channels1 record

Core offering

AusculSciences develops and sells two medical device product lines. The Auscul-X Touchless Stethoscope System is a multi-channel, touch-free, disposable electronic stethoscope with disposable acoustic sensors, an in-room control unit, the AirScope mobile app, and Auscul-XV server software, enabling healthcare professionals to listen to patient heart and lung sounds remotely from up to 3 meters away. The CAD-det System is a noninvasive cardiovascular assessment support device intended for adult patients undergoing clinical evaluation for suspected Coronary Artery Disease.

Product overview

AusculSciences is a medical technology research and development company offering two distinct product lines: the Auscul-X Touchless Stethoscope System, which includes the Auscul-X Control Unit, disposable acoustic sensors, the AirScope mobile app, and Auscul-XV server software for remote auscultation; and the CAD-det System, a noninvasive cardiovascular assessment device for detecting Coronary Artery Disease. The products address different clinical needs—one focuses on infection control during patient monitoring, while the other provides diagnostic support for cardiovascular disease detection.

Differentiator

Problem solved

Functional benefit

Brands

• CAD-det System: Non-invasive cardiovascular assessment support device intended for use on adult patients undergoing clinical evaluation for suspected cardiovascular disease.
• Auscul-X
• AirScope

Products and services

• Auscul-X Touchless Stethoscope System A professional-grade, multi-channel, touch-free, disposable electronic stethoscope system that enables healthcare professionals to listen on-demand and visualize sounds of a patient's heart, lungs, and other internal organs from a safe distance of up to 3 meters, reducing exposure to infectious diseases.
• CAD-det System A noninvasive cardiovascular assessment support device intended for use on adult patients undergoing clinical evaluation for suspected cardiovascular disease. Designed to detect Coronary Artery Disease through analysis of turbulent blood flow sounds in stenosed coronary arteries.
• AirScope Mobile Application Mobile application compatible with Apple, Android, and Windows devices that allows authorized healthcare professionals to listen on-demand and visualize patient heart and lung sounds remotely, including recording, annotation, and sharing capabilities.
• Auscul-XV Server Software Server software that enables healthcare professionals to record, annotate, and share patient auscultation records, improving efficiency and accuracy of consults and shift-changes.

Quantifiable outcome

• Sound quality at 3 meters (10 ft) distance reported as at least equivalent to traditional electronic stethoscope
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Eko Health: Eko Health is a direct competitor in digital/electronic stethoscopes, offering FDA-cleared CORE stethoscopes with AI-assisted cardiac and pulmonary auscultation for clinicians and remote monitoring — closely overlapping with AusculSciences' cardiac and lung-sound capture use case.
• AliveCor: AliveCor (KardiaMobile) produces FDA-cleared, smartphone-connected ECG devices for ambulatory cardiac monitoring, comparable to AusculSciences' mobile/cross-platform cardiac screening and remote-monitoring approach.

Broad incumbents

• Philips (Patient Monitoring): Philips is a broad incumbent in hospital patient monitoring and telehealth, offering continuous vitals and remote cardiac/respiratory monitoring solutions that overlap with AusculSciences' remote auscultation and tele-cardiology workflows.
• GE HealthCare (Patient Monitoring): GE HealthCare supplies hospital-grade patient monitoring and cardiology solutions including bedside and remote cardiac/respiratory monitoring, broadly comparable to the in-room and remote auscultation capabilities of Auscul-X.
• 3M Littmann: 3M Littmann is the dominant incumbent in stethoscopes (including the electronic Littmann CORE line) and competes broadly with AusculSciences in the cardiac/pulmonary auscultation category, though as part of a much larger medical-device portfolio.
• Welch Allyn (Baxter): Welch Allyn, now part of Baxter, is a long-standing incumbent in physical-exam diagnostic instruments (stethoscopes, otoscopes, vital-signs devices), comparable to AusculSciences as an established clinician-facing diagnostic instrument vendor.

Others

• HD Medical (now part of Eko Health): HD Medical pioneered AI-enabled digital stethoscopes for cardiac screening and is referenced here as an adjacent innovator in AI-augmented acoustic cardiac diagnostics, thematically comparable to CAD-det.

Emerging players

• Butterfly Network: Butterfly Network provides handheld, smartphone-connected point-of-care ultrasound used at the bedside for cardiac and pulmonary assessment, an adjacent connected diagnostic device category relevant to AusculSciences' CAD-det positioning.
• iRhythm Technologies: iRhythm's Zio patch is a wearable, single-use ambulatory cardiac monitor with cloud-based analysis — a relevant emerging-player analog for AusculSciences' disposable-sensor, software-backed cardiac diagnostic model.
• StethoMe: StethoMe offers an AI-powered electronic stethoscope and remote lung/heart-sound analysis platform, directly comparable in combining connected acoustic sensors with software-based remote auscultation analysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Customer concentration

• Xx.com/ausculsciences
• Facebookfacebook.com/ausculsciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AusculSciences